생분해성(생흡수성) 폴리머 세계 시장은 2024년 4억 6,080만 달러로 평가되었고, 예측 기간 동안 2030년까지 연평균 4.90%의 안정적인 성장을 보일 것으로 예상됩니다.
재료 분야의 획기적인 기술 발전인 생흡수성 폴리머는 봉합사나 클로르헥시딘 칩과 같은 기계적 제거가 필요 없이 체내에서 분해되는 독특한 특성을 가지고 있습니다. 이러한 생체흡수성 재료는 봉합사, 관상동맥 및 말초혈관 스캐폴딩, 조직 고정용 나사, 뼈 핀 및 앵커, 약물 전달 코팅, 마이크로스피어, 수술용 메쉬, 매트릭스 등 다양한 의료용도에 적용되고 있습니다. 이 카테고리의 재료에는 폴리머, 금속, 세라믹, 유리 및 천연 콜라겐과 같은 생체 유래 재료가 포함되며, 이들은 약물 용출 및 전달을 가능하게 할 뿐만 아니라 기계적 기능도 수행합니다. 현재 생체 흡수성 봉합사는 40여년전부터 판매되어 왔지만, 생체 흡수성 시장은 아직 발전 단계에 있습니다. 최근 기술 혁신으로 시장은 심혈관, 정형외과, 일반외과까지 확대되고 있습니다. 향후 세계 생체 흡수성 봉합사 시장은 정형외과 및 약물 전달과 같은 주요 용도 수요 증가로 인해 큰 폭의 성장이 예상됩니다. 생체 흡수성 시장의 성장에 기여하는 요인으로는 환자의 편의성, 약품 및 의약품 수요 증가, 수술 건수 증가, 사람들의 인식 증가 등을 들 수 있습니다. 다만, 기술적 고도화로 인한 비용 상승은 시장 성장을 저해하는 요인으로 작용할 수 있다는 점은 주의가 필요합니다.
| 시장 개요 | |
|---|---|
| 예측 기간 | 2026-2030년 |
| 시장 규모 : 2024년 | 4억 6,080만 달러 |
| 시장 규모 : 2030년 | 6억 1,543만 달러 |
| CAGR : 2025-2030년 | 4.90% |
| 급성장 부문 | 정형외과 |
| 최대 시장 | 북미 |
헬스케어 분야의 생분해성 및 생체적합성 소재에 대한 수요 증가
생체 적합성 및 안전과 관련된 복잡성
조직공학에 대한 관심 증가
Global Resorbable (Bioresorbable) Polymers Market was valued at USD 460.80 Million in 2024 and is anticipated to project steady growth in the forecast period with a CAGR of 4.90% through 2030. Bioresorbable polymers, a groundbreaking technological advancement in the field of materials, offer a unique characteristic of being broken down by the body without requiring mechanical removal, such as sutures or the chlorhexidine chip. These bioresorbable materials find applications in a wide range of medical indications, including sutures, coronary and peripheral vascular scaffolds, tissue fixation screws, bone pins and anchors, drug delivery coatings, as well as microspheres, surgical meshes, and matrices. The materials in this category encompass polymers, metals, ceramics, glasses, and even materials of biological origin like natural collagen, which not only allow for drug elution and delivery but also serve mechanical functions. Currently, the bioresorbable market is in its developing stage, although bioresorbable sutures have been available for over 40 years. Recent innovations have expanded the market to encompass cardiovascular, orthopedic, and general surgery. Looking ahead, the global bioresorbable market is anticipated to witness substantial growth, driven by the increasing demand from major applications such as orthopedics and drug delivery. Factors contributing to the growth of the bioresorbable market include patient-friendliness, the rising demand for drugs and medicines, the growing number of surgeries, and the increasing awareness among people. However, it is important to note that technological sophistication resulting in higher costs may pose a challenge and restrain the growth of the market.
| Market Overview | |
|---|---|
| Forecast Period | 2026-2030 |
| Market Size 2024 | USD 460.80 Million |
| Market Size 2030 | USD 615.43 Million |
| CAGR 2025-2030 | 4.90% |
| Fastest Growing Segment | Orthopedics |
| Largest Market | North America |
Key Market Drivers
Rising Demand for Biodegradable and Biocompatible Materials in Healthcare
The increasing demand for biodegradable and biocompatible materials in healthcare is a primary factor driving the growth of the global resorbable (bioresorbable) polymers market. As the medical industry shifts towards patient-centric, minimally invasive, and sustainable solutions, bioresorbable polymers are emerging as an essential material class due to their ability to degrade naturally in the body without requiring surgical removal. Traditional medical implants made from metals or permanent synthetic polymers often require secondary surgeries for removal, which increases patient risk, healthcare costs, and recovery time. In contrast, bioresorbable polymers naturally degrade within the body after fulfilling their intended function, eliminating the need for additional procedures. Orthopedic implants, where bioresorbable screws, pins, and plates provide temporary structural support and gradually dissolve as bones heal. Osteoarthritis predominantly impacts individuals aged 55 and older, who account for 73% of cases, with women representing 60% of those affected (1). The condition most commonly affects the knee, with 365 million cases globally, followed by the hip and hand (2). Of these, 344 million people experience moderate to severe symptoms, indicating a significant population that could benefit from targeted rehabilitation interventions. These figures underscore the growing need for effective solutions to address the burden of osteoarthritis, particularly in aging demographics. Cardiovascular stents, which reduce long-term complications by dissolving once arteries regain functionality. In 2022, the global prevalence of coronary artery disease (CAD) was estimated at 315 million cases, with a 95% uncertainty range of 273 million to 362 million. The age-standardized prevalence rate stood at 3,605 cases per 100,000 people (uncertainty interval: 2,892 to 4,454 per 100,000), reflecting an 18% decline from 1990, when the rate was 4,390 per 100,000 (uncertainty interval: 3,510 to 5,445 per 100,000). Regional disparities were significant. Central Europe, Eastern Europe, and Central Asia recorded the highest age-standardized prevalence in 2022, reaching 8,019 cases per 100,000 (uncertainty interval: 6,530 to 9,719 per 100,000). In contrast, South Asia reported the lowest prevalence, at 2,393 cases per 100,000 (uncertainty interval: 1,746 to 3,188 per 100,000). Soft tissue regeneration, where bioresorbable scaffolds promote cell growth and eventually disappear as new tissue forms. The growing preference for temporary, biodegradable implants is a major driver of market growth, as healthcare providers and patients seek safer, more efficient treatment options.
Bioresorbable sutures and meshes are becoming standard in wound closure and surgical applications due to their ability to: Minimize infection risks, as they dissolve naturally and do not require removal. Enhance healing, as they degrade at a controlled rate, reducing tissue damage. Improve patient comfort, eliminating the discomfort of suture removal. The increasing volume of surgeries worldwide-driven by aging populations, chronic diseases, and trauma cases-is further propelling demand for bioabsorbable wound closure products. Pharmaceutical companies are increasingly utilizing bioresorbable polymers in controlled and targeted drug delivery systems. These materials offer several advantages: Sustained drug release, ensuring consistent medication levels over time. Reduced side effects, as localized delivery minimizes systemic exposure. Personalized treatment options, with customizable degradation rates for specific medical needs. Implantable drug delivery systems for chemotherapy, which release drugs at a controlled pace and dissolve after treatment. Microspheres and nanoparticles for long-acting injectable medications in cancer and chronic disease management. Bioresorbable coatings on medical devices, enhancing their therapeutic effectiveness. The push towards precision medicine and advanced drug delivery technologies is significantly boosting demand for bioresorbable polymers.
Key Market Challenges
Complexities Associated with Biocompatibility and Safety
Bioresorbable polymers are highly regarded for their exceptional biocompatibility, which enables them to be safely absorbed by the body once their purpose is fulfilled. This outstanding quality makes them ideal for a wide range of applications in the medical field, including medical devices and drug delivery systems, as well as various biomedical applications.
However, achieving the desired level of biocompatibility is a complex and intricate process. While synthetic polymers can help avoid issues with immunogenicity, they can introduce new challenges in ensuring biocompatibility. Thus, the development of bioresorbable polymers requires a delicate balance to ensure that these materials interact with the body without causing any adverse reactions.
In addition to biocompatibility, safety is another crucial aspect when it comes to bioresorbable polymers. Scientific evaluations have indicated that these polymers are generally safe for use in medical devices. However, their safety profile primarily depends on their design and how they degrade within the body. It is crucial that the degradation process of bioresorbable polymers is both predictable and safe, without causing any harm to the body. This necessitates rigorous testing and stringent quality control measures, adding yet another layer of complexity to the development and production of these materials.
Undoubtedly, the complexities associated with biocompatibility and safety pose significant challenges for the resorbable polymers market. These challenges can impede product development, elevate costs, and create barriers to market entry. Nonetheless, these complexities also serve as drivers for innovation within the market. They compel companies to invest in extensive research and development efforts, leading to the creation of advanced bioresorbable polymers with improved biocompatibility and enhanced safety profiles. By addressing these challenges head-on, the industry can pave the way for groundbreaking advancements in the field of bioresorbable polymers.
Key Market Trends
Growing Focus on Tissue Engineering
Tissue engineering, a highly interdisciplinary field, aims to develop functional tissues to restore, maintain, or enhance damaged tissues or whole organs. It involves the use of resorbable polymers as scaffolds, providing a three-dimensional structure for the growth of new tissue. These polymers, known for their biocompatibility and ability to safely degrade within the body, are ideal for tissue engineering applications.
The rising focus on regenerative medicine and tissue engineering is driving the demand for resorbable polymers. This growing trend has significant implications for the resorbable polymers market. Firstly, it leads to an increased demand for these materials, contributing to market growth. The application of resorbable polymers in tissue engineering is expected to continue expanding, further fueling the demand.
Moreover, this trend also spurs innovation in the market. With the increasing use of polymers in tissue engineering, companies are motivated to develop advanced bioresorbable polymers with improved properties, such as enhanced strength and flexibility. This drive for innovation pushes the boundaries of what is possible in tissue engineering.
Furthermore, the emphasis on tissue engineering encourages extensive research and development efforts in the field of resorbable polymers. This results in ongoing product developments and a significant increase in investment in research and development activities. Scientists and engineers strive to optimize the properties and performance of resorbable polymers, paving the way for breakthroughs in tissue engineering applications.
In conclusion, the growing focus on tissue engineering represents a significant and transformative trend in the global resorbable polymers market. As the field of tissue engineering continues to evolve and expand, the role of resorbable polymers in this field is set to become increasingly important, positively impacting the market's growth. The continuous advancements in resorbable polymers hold tremendous potential for revolutionizing regenerative medicine and improving patients' lives.
In this report, the Global Resorbable (Bioresorbable) Polymers Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Resorbable (Bioresorbable) Polymers Market.
Global Resorbable (Bioresorbable) Polymers Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: